vs
Side-by-side financial comparison of EyePoint, Inc. (EYPT) and PureCycle Technologies, Inc. (PCT). Click either name above to swap in a different company.
EyePoint, Inc. is the larger business by last-quarter revenue ($5.3M vs $2.7M, roughly 2.0× PureCycle Technologies, Inc.). PureCycle Technologies, Inc. runs the higher net margin — -697.1% vs -1114.3%, a 417.2% gap on every dollar of revenue. PureCycle Technologies, Inc. produced more free cash flow last quarter ($-42.0M vs $-63.8M).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.
EYPT vs PCT — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $2.7M |
| Net Profit | $-59.4M | $-18.8M |
| Gross Margin | — | — |
| Operating Margin | -1166.8% | -2196.1% |
| Net Margin | -1114.3% | -697.1% |
| Revenue YoY | -43.7% | — |
| Net Profit YoY | -92.8% | 71.0% |
| EPS (diluted) | $-0.85 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | $5.3M | $1.6M | ||
| Q1 25 | $24.5M | $1.6M | ||
| Q4 24 | $11.6M | $0 | ||
| Q3 24 | $10.5M | $0 | ||
| Q2 24 | $9.5M | $0 | ||
| Q1 24 | $11.7M | $0 |
| Q4 25 | — | $-18.8M | ||
| Q3 25 | — | $-28.4M | ||
| Q2 25 | $-59.4M | $-144.2M | ||
| Q1 25 | $-45.2M | $8.8M | ||
| Q4 24 | $-41.4M | $-64.7M | ||
| Q3 24 | $-29.4M | $-90.6M | ||
| Q2 24 | $-30.8M | $-48.2M | ||
| Q1 24 | $-29.3M | $-85.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 93.0% | — | ||
| Q2 24 | 85.2% | — | ||
| Q1 24 | 93.5% | — |
| Q4 25 | — | -2196.1% | ||
| Q3 25 | — | -1602.2% | ||
| Q2 25 | -1166.8% | -2763.5% | ||
| Q1 25 | -199.7% | -2387.4% | ||
| Q4 24 | -390.4% | — | ||
| Q3 24 | -311.2% | — | ||
| Q2 24 | -364.5% | — | ||
| Q1 24 | -285.2% | — |
| Q4 25 | — | -697.1% | ||
| Q3 25 | — | -1167.5% | ||
| Q2 25 | -1114.3% | -8741.8% | ||
| Q1 25 | -184.8% | 559.0% | ||
| Q4 24 | -357.3% | — | ||
| Q3 24 | -279.0% | — | ||
| Q2 24 | -325.3% | — | ||
| Q1 24 | -250.6% | — |
| Q4 25 | — | $-0.14 | ||
| Q3 25 | — | $-0.31 | ||
| Q2 25 | $-0.85 | $-0.81 | ||
| Q1 25 | $-0.65 | $0.05 | ||
| Q4 24 | $-0.65 | $-0.40 | ||
| Q3 24 | $-0.54 | $-0.54 | ||
| Q2 24 | $-0.58 | $-0.29 | ||
| Q1 24 | $-0.55 | $-0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.7M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.0M | $45.9M |
| Total Assets | $301.1M | $922.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $156.7M | ||
| Q3 25 | — | $234.4M | ||
| Q2 25 | $255.7M | $284.1M | ||
| Q1 25 | $318.2M | $22.5M | ||
| Q4 24 | $370.9M | $15.7M | ||
| Q3 24 | $253.8M | $83.7M | ||
| Q2 24 | $280.2M | $10.9M | ||
| Q1 24 | $299.3M | $25.0M |
| Q4 25 | — | $45.9M | ||
| Q3 25 | — | $68.2M | ||
| Q2 25 | $246.0M | $98.9M | ||
| Q1 25 | $298.4M | $238.2M | ||
| Q4 24 | $336.5M | $180.4M | ||
| Q3 24 | $218.7M | $241.4M | ||
| Q2 24 | $228.3M | $291.6M | ||
| Q1 24 | $249.9M | $336.8M |
| Q4 25 | — | $922.7M | ||
| Q3 25 | — | $989.1M | ||
| Q2 25 | $301.1M | $1.0B | ||
| Q1 25 | $362.6M | $787.3M | ||
| Q4 24 | $418.5M | $798.4M | ||
| Q3 24 | $300.9M | $788.8M | ||
| Q2 24 | $324.2M | $719.8M | ||
| Q1 24 | $329.2M | $734.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-62.6M | $-28.7M |
| Free Cash FlowOCF − Capex | $-63.8M | $-42.0M |
| FCF MarginFCF / Revenue | -1196.5% | -1559.6% |
| Capex IntensityCapex / Revenue | 22.9% | 495.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-194.0M | $-183.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-28.7M | ||
| Q3 25 | — | $-38.5M | ||
| Q2 25 | $-62.6M | $-36.7M | ||
| Q1 25 | $-53.1M | $-38.9M | ||
| Q4 24 | $-35.8M | $-31.8M | ||
| Q3 24 | $-39.0M | $-33.4M | ||
| Q2 24 | $-20.2M | $-40.4M | ||
| Q1 24 | $-31.2M | $-39.2M |
| Q4 25 | — | $-42.0M | ||
| Q3 25 | — | $-42.4M | ||
| Q2 25 | $-63.8M | $-45.3M | ||
| Q1 25 | $-53.4M | $-53.9M | ||
| Q4 24 | $-36.2M | $-53.4M | ||
| Q3 24 | $-40.6M | $-42.6M | ||
| Q2 24 | $-21.1M | $-50.8M | ||
| Q1 24 | $-32.4M | $-53.5M |
| Q4 25 | — | -1559.6% | ||
| Q3 25 | — | -1743.1% | ||
| Q2 25 | -1196.5% | -2747.1% | ||
| Q1 25 | -218.4% | -3409.6% | ||
| Q4 24 | -312.7% | — | ||
| Q3 24 | -385.8% | — | ||
| Q2 24 | -222.4% | — | ||
| Q1 24 | -277.0% | — |
| Q4 25 | — | 495.1% | ||
| Q3 25 | — | 160.3% | ||
| Q2 25 | 22.9% | 521.5% | ||
| Q1 25 | 1.1% | 949.6% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 9.5% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
